Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Non-Current Assets (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Non-Current Assets for 3 consecutive years, with $191.0 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 13.15% to $191.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $736.6 million through Dec 2025, changed N/A year-over-year, with the annual reading at $191.0 million for FY2025, 13.15% up from the prior year.
  • Non-Current Assets hit $191.0 million in Q4 2025 for Guardian Pharmacy Services, roughly flat from $191.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $191.8 million in Q3 2025 to a low of $141.6 million in Q4 2023.
  • Historically, Non-Current Assets has averaged $173.5 million across 3 years, with a median of $168.8 million in 2024.
  • Biggest five-year swings in Non-Current Assets: grew 19.26% in 2024 and later grew 13.15% in 2025.
  • Year by year, Non-Current Assets stood at $141.6 million in 2023, then rose by 19.26% to $168.8 million in 2024, then grew by 13.15% to $191.0 million in 2025.
  • Business Quant data shows Non-Current Assets for GRDN at $191.0 million in Q4 2025, $191.8 million in Q3 2025, and $185.9 million in Q2 2025.